FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2729511000001107: Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25918501000001118 Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25918601000001119 Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Is a Nortriptyline 30mg / Fluphenazine 1.5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Is pack of Motipress tablets (Sanofi-Synthelabo Ltd) false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has active ingredient Nortriptyline hydrochloride false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has active ingredient Fluphenazine hydrochloride false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has active ingredient Nortriptyline false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has excipient Beeswax false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has AMP Motipress tablets (Sanofi-Synthelabo Ltd) true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nortriptyline true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has specific active ingredient Nortriptyline hydrochloride true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has specific active ingredient Fluphenazine hydrochloride true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has basis of strength substance Nortriptyline true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start